TITLE

Macrolide use and antibiotic resistance

AUTHOR(S)
Stapleton, F. Bruder
PUB. DATE
July 2007
SOURCE
Archives of Disease in Childhood;Jul2007, Vol. 92 Issue 7, p650
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a summary of a study on the macrolide use and antibiotic resistance as well as its commentary. Results of the study show that the two macrolides commonly used for treating respiratory infections, azithromycin and clarithromycin, caused macrolide-resistant streptococci in healthy volunteers. Moreover, azithromycin initially caused greater proportion of macrolide-resistant streptococci than clarithromycin.
ACCESSION #
25765858

 

Related Articles

  • Macrolide-Resistant Group A Streptococcus – Now in the United States. Huovinen, Pentti // New England Journal of Medicine;4/18/2002, Vol. 346 Issue 16, p1243 

    The article focuses on the use of antibiotics for the treatment of respiratory tract infections. It is mentioned that group A streptococcus is a common bacterial pathogen that causes tonsillitis and skin infections. It is suggested that macrolide antibiotics, such as erythromycin,...

  • Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Jenkins, Stephen G.; Brown, Steven D.; Farrell, David J. // Annals of Clinical Microbiology & Antimicrobials;2008, Vol. 7, Special section p1 

    Background: The increasing prevalence of resistance to established antibiotics among key bacterial respiratory tract pathogens, such as Streptococcus pneumoniae, is a major healthcare problem in the USA. The PROTEKT US study is a longitudinal surveillance study designed to monitor the...

  • Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers. Eisenblätter, M.; Klaus, C.; Pletz, M. W. R.; Orawa, H.; Hahn, H.; Wagner, J.; Lode, H. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2008, Vol. 27 Issue 11, p1087 

    Oral viridans streptococci are a reservoir of resistance genes for pathogens. Through prolonged exposure, long-acting macrolides (e.g., azithromycin) may induce the resistance of the commensals to macrolides more frequently than macrolides with a shorter half-life (e.g., clarithromycin). In a...

  • Macrolide use affects proportions of macrolide-resistant streptococci.  // PharmacoEconomics & Outcomes News;2/24/2007, Issue 522, p8 

    The article discusses research being done on the effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci. It references a study by S. Malhotra-Kumar et al published in the February 10, 2007 issue of "Lancet." Findings indicated that the...

  • The Decline of Pneumococcal Resistance after Cessation of Mass Antibiotic Distributions for Trachoma. Haug, Sara; Lakew, Takele; Habtemariam, Gabremaskal; Alemayehu, Wondu; Cevallos, Vicky; Zhaoxia Zhou; House, Jenafir; Ray, Kathryn; Porco, Travis; Rutar, Tina; Keenan, Jeremy; Lietman, Thomas M.; Gaynor, Bruce D. // Clinical Infectious Diseases;9/1/2010, Vol. 51 Issue 5, p571 

    After 6 biannual mass distributions of oral azithromycin for trachoma in Ethiopian communities, 76.8% (95% confidence interval [CI], 66.3%-85.1%) of nasopharyngeal Streptococcus pneumoniae isolates from children aged 1-5 years were resistant to macrolides. Twelve and 24 months after the last...

  • Clinical Relevance of Macrolide-Resistant Streptococcus pneumoniae for Community-Acquired Pneumonia. Lynch III, Joseph P.; Martinez, Fernando J. // Clinical Infectious Diseases;3/1/2002 Supplement 1, Vol. 34, pS27 

    Discusses the prevalence of macrolide resistance among Streptococcus pneumoniae, risk factors and mechanisms responsible for resistance, therapeutic strategies and implications for the future. Impact of antimicrobial resistance on clinical outcomes; Clinical significance of in vitro macrolide...

  • Macrolide Resistance and Distribution of erm and mef Genes Among Beta-Haemolytic Streptococci in Hong Kong. Ip, M.; Lyon, D. J.; Leung, T.; Cheng, A. F. B. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2002, Vol. 21 Issue 3, p238 

    This article focuses on macrolide resistance and distribution of erm and mef genes among beta-haemolytic Streptococci in Hong Kong. Macrolide resistance has increased significantly among Streptococcus pneumonia as a result of the clonal spread of penicillin-resistant pneumococci. Two major...

  • Increasing telithromycin resistance among Streptococcus pyogenes in Europe. Sandra S. Richter; Kristopher P. Heilmann; Cassie L. Dohrn; Susan E. Beekmann; Fathollah Riahi; Juan Garcia-de-Lomas; Matus Ferech; Herman Goossens; Gary V. Doern // Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p603 

    : Objectives To assess changes in macrolide and ketolide resistance among Streptococcus pyogenes in Europe and to examine the relationship of resistance to antimicrobial usage. : Methods Clinical S. pyogenes isolates were collected from Denmark, Finland, France, Germany, Italy, Netherlands,...

  • Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes. Jalava, Jari; Vaara, Martti; Huovinen, Pentti // Annals of Clinical Microbiology & Antimicrobials;2004, Vol. 3, p1 

    Background: In streptococci, three macrolide resistance determinants (erm(B), erm(TR) and mef(A)) have been found. In addition, certain mutations at the ribosomal 23S RNA can cause resistance to macrolides. Mutation at the position 2058 of the 23S rRNA of the Streptococcus pyogenes as a cause of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics